Imaging for precision medicine: can V‐P SPECT measure mepolizumab response in asthma?

Imaging for precision medicine: can V‐P SPECT measure mepolizumab response in asthma?

Abstract Monoclonal antibody therapies are effective for many but not all people with severe asthma. Precision medicine guides treatment selection using biomarkers to select patients most likely to respond according to their inflammatory endotypes. However, when assessing response to treatment, grea...

Full description

Bibliographic Details
Main Authors: Vanessa M. McDonald, Paola D. Urroz, Marika Bajc, Natalie Rutherford, Bree Brooker, Peter G. Gibson
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Respirology Case Reports
Subjects:
Mepolizumab
severe asthma
treatable traits
ventilation
V‐P SPECT
Online Access:https://doi.org/10.1002/rcr2.717

Similar Items

Similar Items